FTH news

Latest 4 stories · newest Nov 3, 2026

FTH

Faeth Therapeutics Announces Q3 2026 Results, Nears Phase 2 Topline Data

Faeth Therapeutics reported Q3 financial results, successfully reaching operational milestones like the Fast Track designation for PIKTOR and presenting preclinical data for breast cancer. This update, revealing expected data by year-end, signals progress in their multi-node cancer therapy pipeline.

Leadership|Regulatory|Other Nov 3, 2026 sentiment +0.40 SEC filing ↗

FTH

Faeth Therapeutics posts $186.4M cash and announces Q2 2026 results

Faeth Therapeutics' cash surged due to a $200M PIPE financing, with top-line Phase 2 data from the PIK-201 trial in endometrial cancer expected year-end, starkly contrasting with its previous $21.2M cash position.

Offering Aug 4, 2026 sentiment +0.65 SEC filing ↗

FTH

This IBM Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday

Trading Ideas Jun 23, 2026 sentiment 0.00 Source: benzinga.com ↗

FTH

This Apple Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday

Trading Ideas Jun 22, 2026 sentiment 0.00 Source: benzinga.com ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same FTH feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/FTH/newsSTART FREE